清开灵联合单唾液酸四己糖神经节苷脂钠治疗重症脑梗死的疗效观察

Observation on treating severe cerebral infarction with Qingkailing plus GM1

目的:观察清开灵注射液联合单唾液酸四己糖神经节苷脂(GM1)钠注射液治疗重症脑梗死的临床效果。方法:将临床确诊为重症脑梗死的患者60例随机分为两组,在常规治疗的基础上,对照组给予胞二磷胆碱钠注射液治疗,治疗组给予清开灵注射液联合单唾液酸四己糖神经节苷脂钠注射液治疗。结果:治疗组疗效优于对照组,治疗组的神经功能缺损程度评分显著降低,与对照组比较差异有显著性(P<0.05)。结论:清开灵注射液联合单唾液酸四己糖神经节苷脂钠注射液治疗重症脑梗死能显著改善患者的临床症状,促进神经功能恢复,提高疗效。

Objective To observe the effects of Qingkailing plus GM1 on severe cerebral infarction. Methods： 60 cases were randomly divided into two groups and given conventional therapy. The control group received citicoline sodium injection; the treatment group received Qingkailing plus GM1 injections. Results： The efcacy in the treatment group was better than that in the control group; the degree of the neurological defcit in the treatment group was decreased signifcantly, with a signifcant diference compared with the control group （P〈0.05）. Conclusion： Qingkailing plus GM1 on severe cerebral infarction can signifcantly improve symptoms, promote the recovery of neurological function, and improve the curative efect.